Development and Validation of Simultaneous Estimation of Glycopyrrolate and Formoterol Fumarate in its Bulk and Pharmaceutical Rota Caps Dosage form by using RP-UPLC

International Journal of Applied Chemistry

© 2020 by SSRG - IJAC Journal

Volume 7 Issue 3

Year of Publication : 2020

Authors : Venkateswara Reddy.Billa, Anuradha.Vejendla, Ramachandran.Dittakavi, Naveen Reddy.Seelam

10.14445/23939133/IJAC-V7I3P110

How to Cite?

Venkateswara Reddy.Billa, Anuradha.Vejendla, Ramachandran.Dittakavi, Naveen Reddy.Seelam, "Development and Validation of Simultaneous Estimation of Glycopyrrolate and Formoterol Fumarate in its Bulk and Pharmaceutical Rota Caps Dosage form by using RP-UPLC," SSRG International Journal of Applied Chemistry, vol. 7,  no. 3, pp. 49-56, 2020. Crossref, https://doi.org/10.14445/23939133/IJAC-V7I3P110

Abstract:

A new, simple, rapid, selective, precise, and accurate isocratic reverse-phase high-performance liquid Chromatography assay method has been developed for simultaneous estimation of Glycopyrrolate and Formoterol Fumarate tablet formulations. The separation was achieved by using column BEH C18 (2.6m x 50mm 1.8m) in the mobile phase consisted of pH 2.5 triethyl amine buffer and Methanol in the ratio of 50:50 v/v. The flow rate was 0.2 mL/min, column oven temperature 25° C, the injection volume was 6 μL, and detection was performed at 250 nm using a photodiode array detector (PDA), Run time 6 minutes. The retention time of Glycopyrrolate and Formoterol Fumarate was noted to be 0.68 minutes and 1.05 minutes respectively, indicative of rather shorter analysis time. The method was validated as per ICH guidelines. The proposed method was found to be accurate, reproducible, and consistent.

Keywords:

Liquid Chromatography; Glycopyrrolate, Formoterol Fumarate, combined dosage forms; Simultaneous estimation, Validation.

References:

[1] Bevespi Aerosphere™ (glycopyrrolate and formoterol fumigate) Prescribing information, AstraZeneca 2016.
[2] https://www.drugs.com/pro/glycopyrrolate-injection.html
[3] Mishra S, Arora V (2016). International Journal for Pharmaceutical Research Scholars.;5(4):101-4.
[4] Shah PD, Koradia S. (2014) World Journal of Pharmacy and Pharmaceutical Sciences.;3(5):611-23.
[5] Pabba KG, Akula G (2011). Asian Journal of Pharmaceutical and Clinical Research.;4(4):37-40.
[6] Stormea ML, t’Kindt RS, Goeteyn W, Reyntjens K, Van Bocxlaer JF (2008). Journal of Chromatogr. B.;876(1):24-30.
[7] Rumpler MJ, Sams RA, Colahan P (2011). Validation of liquid chromatography-tandem mass spectrometry method for quantification of Glycopyrrolate in horse plasma Journal of Analytical Toxicology.;35(9):656-64.
[8] Campestrini J, Lecaillon JB, Godbillon J (1997). Journal of Chromatogr. B.;704(1-2):221-9.
[9] Srinivasu K, Rao JV, Raju NA, Mukkanti K (2010). Asian Journal of Chemistry.;22(5):3943-8.
[10] Nanasaheb RK, Ashok PP, Javed AM, Govind ND (2014). World Journal of Pharmaceutical Research.;3(6):1386-99.
[11] Zanwar AS, Sen DB, Ruikar DB, Seth AK (2014). Indo American Journal of Pharmaceutical Research.;4(12):5928-33.
[12] Merey HA, El-Mosallamy SS, Hassan NY, El-Zeany BA (2016). Bulletin of Faculty of Pharmacy, Cairo University.;54(1):99-106.
[13] Srinivasarao K, Gorule V, Venkata RCh, Venkata KA (2012). Journal of Analytical and Bioanalytical Techniques.;3(7):1-4.
[14] Prasad AV (2006). Indian Journal of Chemical Technology.;13:81-3.
[15] Pai N, Patil SS (2013). Der Pharmacia Sinica.;4(4):15-25.
[16] Malik K, Kumar D, Tomar V, Kaskhedikar S, Soni L (2011). Der Pharmacia Sinica.;2(6):77-84.
[17] ICH harmonized tripartite guideline; validation of Analytical procedures: Text and Methodology Q2 (R1). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2005. 11-12.